Clinical Trials Browser

Phase 1 × PM 01183 × 1 year × Clear all

NCT05636111 2026-01-22

Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer

Phase 1 Recruiting

Ovarian Neoplasms

NCT05072106 2025-09-16

Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid Tumors

Phase 1 Completed

11 enrolled 26 charts

Other solid neoplasm

Advanced Solid Tumor

NCT05063318 2025-09-02

Clinical Trial of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors

Phase 1 Completed

14 enrolled 20 charts

Other solid neoplasm

Advanced Solid Tumors